TransMedics Group, Inc. (TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 28, 2019
Market Capitalization	2,688	2,577	1,970	532	541	393
Market Cap Growth	193.16%	30.78%	270.34%	-1.57%	37.38%	-
Enterprise Value	2,779	2,665	1,834	464	442	339
Last Close Price	77.20	78.93	61.72	19.16	19.90	18.59
PS Ratio	6.35	10.66	21.08	17.58	21.08	16.67
PB Ratio	12.34	18.78	10.52	7.84	5.20	7.20
P/TBV Ratio	26.70	20.97	10.52	7.84	5.20	7.20
EV/Sales Ratio	6.93	11.03	19.62	15.34	17.25	14.37
EV/EBITDA Ratio	54.34	307.71	-	-	-	-
EV/EBIT Ratio	83.07	5495.72	-	-	-	-
Debt / Equity Ratio	2.47	3.76	0.36	0.65	0.33	0.62
Debt / EBITDA Ratio	9.03	38.35	-	-	-	-
Asset Turnover	0.54	0.49	0.45	0.21	0.20	0.32
Inventory Turnover	3.56	2.70	1.59	0.68	0.78	0.95
Quick Ratio	7.00	8.34	9.67	4.23	11.15	5.41
Current Ratio	8.20	9.30	10.66	5.11	12.36	6.21
Return on Equity (ROE)	19.41%	-15.42%	-28.39%	-51.49%	-36.27%	-134.66%
Return on Assets (ROA)	2.84%	0.06%	-9.54%	-17.18%	-12.82%	-25.09%
Return on Capital (ROIC)	3.05%	0.07%	-10.72%	-19.70%	-14.51%	-31.45%
Earnings Yield	1.26%	-0.97%	-1.84%	-8.31%	-5.32%	-8.53%
FCF Yield	-4.65%	-6.40%	-2.93%	-6.09%	-5.68%	-8.25%
Buyback Yield / Dilution	-6.83%	-10.02%	-7.02%	-11.80%	-73.90%	-945.47%
Total Shareholder Return	-6.83%	-10.02%	-7.02%	-11.80%	-73.90%	-945.47%

Source: S&P Capital IQ. Standard template. Financial Sources.